Lactobacillus brevis FROM GAMITANA (Colossoma macropomum) SHOWS PROBIOTIC POTENTIAL WITH ANTAGONISTIC ACTIVITY AGAINST Lactococcus garvieae PATHOGEN

Descripción del Articulo

Autochthonous probiotics derived from the host’s native microbiota can enhance gastrointestinal colonization, feed efficiency, disease resistance, and stress tolerance in aquaculture species. This study evaluated bacteria isolated from the intestine and gills of gamitana (Colossoma macropomum) based...

Descripción completa

Detalles Bibliográficos
Autores: TOLEDO VALDIVIEZO, Odalis Epifanía, ZATAN, Adrian E., CASTAÑEDA, Arnaldo Edward, AGUILAR, Jorge Luis, MANEIRO, Iñigo, DIRINGER, Benoit, FERIA, Manuel Alberto
Formato: artículo
Fecha de Publicación:2025
Institución:Instituto de investigaciones de la Amazonía Peruana
Repositorio:Folia Amazónica
Lenguaje:inglés
OAI Identifier:oai:ojs.pkp.sfu.ca:article/803
Enlace del recurso:https://revistas.iiap.gob.pe/index.php/foliaamazonica/article/view/803
Nivel de acceso:acceso abierto
Materia:tambaqui
amazon fish
gut
probiotic
Tambaqui
pez amazónico
intestino
probiótico
id REVIIAP_81b54c2bca3eac227bf43837a4947a6f
oai_identifier_str oai:ojs.pkp.sfu.ca:article/803
network_acronym_str REVIIAP
network_name_str Folia Amazónica
repository_id_str
dc.title.none.fl_str_mv Lactobacillus brevis FROM GAMITANA (Colossoma macropomum) SHOWS PROBIOTIC POTENTIAL WITH ANTAGONISTIC ACTIVITY AGAINST Lactococcus garvieae PATHOGEN
Lactobacillus brevis AISLADOS DE GAMITANA (Colossoma macropomum) MUESTRAN POTENCIAL PROBIÓTICO CON ACTIVIDAD ANTAGONISTA CONTRA EL PATÓGENO Lactococcus garvieae
title Lactobacillus brevis FROM GAMITANA (Colossoma macropomum) SHOWS PROBIOTIC POTENTIAL WITH ANTAGONISTIC ACTIVITY AGAINST Lactococcus garvieae PATHOGEN
spellingShingle Lactobacillus brevis FROM GAMITANA (Colossoma macropomum) SHOWS PROBIOTIC POTENTIAL WITH ANTAGONISTIC ACTIVITY AGAINST Lactococcus garvieae PATHOGEN
TOLEDO VALDIVIEZO, Odalis Epifanía
tambaqui
amazon fish
gut
probiotic
Tambaqui
pez amazónico
intestino
probiótico
title_short Lactobacillus brevis FROM GAMITANA (Colossoma macropomum) SHOWS PROBIOTIC POTENTIAL WITH ANTAGONISTIC ACTIVITY AGAINST Lactococcus garvieae PATHOGEN
title_full Lactobacillus brevis FROM GAMITANA (Colossoma macropomum) SHOWS PROBIOTIC POTENTIAL WITH ANTAGONISTIC ACTIVITY AGAINST Lactococcus garvieae PATHOGEN
title_fullStr Lactobacillus brevis FROM GAMITANA (Colossoma macropomum) SHOWS PROBIOTIC POTENTIAL WITH ANTAGONISTIC ACTIVITY AGAINST Lactococcus garvieae PATHOGEN
title_full_unstemmed Lactobacillus brevis FROM GAMITANA (Colossoma macropomum) SHOWS PROBIOTIC POTENTIAL WITH ANTAGONISTIC ACTIVITY AGAINST Lactococcus garvieae PATHOGEN
title_sort Lactobacillus brevis FROM GAMITANA (Colossoma macropomum) SHOWS PROBIOTIC POTENTIAL WITH ANTAGONISTIC ACTIVITY AGAINST Lactococcus garvieae PATHOGEN
dc.creator.none.fl_str_mv TOLEDO VALDIVIEZO, Odalis Epifanía
ZATAN, Adrian E.
CASTAÑEDA, Arnaldo Edward
AGUILAR, Jorge Luis
MANEIRO, Iñigo
DIRINGER, Benoit
FERIA, Manuel Alberto
TOLEDO VALDIVIEZO, Odalis Epifanía
ZATAN, Adrian E.
CASTAÑEDA, Arnaldo Edward
AGUILAR, Jorge Luis
MANEIRO, Iñigo
DIRINGER, Benoit
FERIA, Manuel Alberto
author TOLEDO VALDIVIEZO, Odalis Epifanía
author_facet TOLEDO VALDIVIEZO, Odalis Epifanía
ZATAN, Adrian E.
CASTAÑEDA, Arnaldo Edward
AGUILAR, Jorge Luis
MANEIRO, Iñigo
DIRINGER, Benoit
FERIA, Manuel Alberto
author_role author
author2 ZATAN, Adrian E.
CASTAÑEDA, Arnaldo Edward
AGUILAR, Jorge Luis
MANEIRO, Iñigo
DIRINGER, Benoit
FERIA, Manuel Alberto
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv tambaqui
amazon fish
gut
probiotic
Tambaqui
pez amazónico
intestino
probiótico
topic tambaqui
amazon fish
gut
probiotic
Tambaqui
pez amazónico
intestino
probiótico
description Autochthonous probiotics derived from the host’s native microbiota can enhance gastrointestinal colonization, feed efficiency, disease resistance, and stress tolerance in aquaculture species. This study evaluated bacteria isolated from the intestine and gills of gamitana (Colossoma macropomum) based on key probiotic selection criteria, including tolerance to acidic conditions and bile salts, antagonistic activity against pathogens, antibiotic susceptibility, biofilm formation, and enzymatic activity. A total of 69 bacterial isolates were obtained using Man, Rogosa, and Sharpe (MRS) broth and Trypticase Soy Broth (TSB). Five isolates (7.2%) met all selection criteria and were molecularly identified as Lactobacillus brevis (IPIFAB2, IPIFAC1, BRALA1) and Lactococcus garvieae (G25, G23). L. brevis isolates showed moderate acid tolerance, with survival rates between 31 ± 2.04% and 36.4 ± 0.17% at pH 4. All selected strains tolerated bile salts; however, L. brevis maintained high viability (≥78% at 0.8%), while L. garvieae exhibited marked reductions at higher concentrations. Antagonistic activity was significantly greater in L. brevis, producing inhibition halos of 2.3 ± 0.1 to 3.9 ± 0.1 mm, compared with 1.2 ± 0.21 to 1.9 ± 0.12 mm for L. garvieae. Proteolytic activity was observed in three L. brevis strains, and six isolates demonstrated biofilm-forming capacity. All selected strains were susceptible to the antibiotics tested. Among them, L. brevis IPIFAB2 exhibited the strongest probiotic profile. Overall, L. brevis strains show considerable potential as autochthonous probiotics for C. macropomum aquaculture, contributing to improved fish health, disease prevention, and sustainable production.
publishDate 2025
dc.date.none.fl_str_mv 2025-06-30
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Articles
Artículos
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistas.iiap.gob.pe/index.php/foliaamazonica/article/view/803
10.24841//fa.v34i1.803
url https://revistas.iiap.gob.pe/index.php/foliaamazonica/article/view/803
identifier_str_mv 10.24841//fa.v34i1.803
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://revistas.iiap.gob.pe/index.php/foliaamazonica/article/view/803/677
dc.rights.none.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Instituto de Investigaciones de la Amazonia Peruana
publisher.none.fl_str_mv Instituto de Investigaciones de la Amazonia Peruana
dc.source.none.fl_str_mv Folia Amazonica; Vol. 34 No. 1 (2025); e34803
Folia Amazónica; Vol. 34 Núm. 1 (2025); e34803
Folia Amazónica; v. 34 n. 1 (2025); e34803
2410-1184
1018-5674
10.24841/fa.v34i1
reponame:Folia Amazónica
instname:Instituto de investigaciones de la Amazonía Peruana
instacron:IIAP
instname_str Instituto de investigaciones de la Amazonía Peruana
instacron_str IIAP
institution IIAP
reponame_str Folia Amazónica
collection Folia Amazónica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1867988743071203328
spelling Lactobacillus brevis FROM GAMITANA (Colossoma macropomum) SHOWS PROBIOTIC POTENTIAL WITH ANTAGONISTIC ACTIVITY AGAINST Lactococcus garvieae PATHOGENLactobacillus brevis AISLADOS DE GAMITANA (Colossoma macropomum) MUESTRAN POTENCIAL PROBIÓTICO CON ACTIVIDAD ANTAGONISTA CONTRA EL PATÓGENO Lactococcus garvieaeTOLEDO VALDIVIEZO, Odalis EpifaníaZATAN, Adrian E.CASTAÑEDA, Arnaldo EdwardAGUILAR, Jorge LuisMANEIRO, IñigoDIRINGER, BenoitFERIA, Manuel AlbertoTOLEDO VALDIVIEZO, Odalis EpifaníaZATAN, Adrian E.CASTAÑEDA, Arnaldo EdwardAGUILAR, Jorge LuisMANEIRO, IñigoDIRINGER, BenoitFERIA, Manuel Albertotambaquiamazon fishgutprobioticTambaquipez amazónicointestinoprobióticoAutochthonous probiotics derived from the host’s native microbiota can enhance gastrointestinal colonization, feed efficiency, disease resistance, and stress tolerance in aquaculture species. This study evaluated bacteria isolated from the intestine and gills of gamitana (Colossoma macropomum) based on key probiotic selection criteria, including tolerance to acidic conditions and bile salts, antagonistic activity against pathogens, antibiotic susceptibility, biofilm formation, and enzymatic activity. A total of 69 bacterial isolates were obtained using Man, Rogosa, and Sharpe (MRS) broth and Trypticase Soy Broth (TSB). Five isolates (7.2%) met all selection criteria and were molecularly identified as Lactobacillus brevis (IPIFAB2, IPIFAC1, BRALA1) and Lactococcus garvieae (G25, G23). L. brevis isolates showed moderate acid tolerance, with survival rates between 31 ± 2.04% and 36.4 ± 0.17% at pH 4. All selected strains tolerated bile salts; however, L. brevis maintained high viability (≥78% at 0.8%), while L. garvieae exhibited marked reductions at higher concentrations. Antagonistic activity was significantly greater in L. brevis, producing inhibition halos of 2.3 ± 0.1 to 3.9 ± 0.1 mm, compared with 1.2 ± 0.21 to 1.9 ± 0.12 mm for L. garvieae. Proteolytic activity was observed in three L. brevis strains, and six isolates demonstrated biofilm-forming capacity. All selected strains were susceptible to the antibiotics tested. Among them, L. brevis IPIFAB2 exhibited the strongest probiotic profile. Overall, L. brevis strains show considerable potential as autochthonous probiotics for C. macropomum aquaculture, contributing to improved fish health, disease prevention, and sustainable production.Los probióticos autóctonos derivados de la microbiota nativa del huésped pueden mejorar la colonización gastrointestinal, la eficiencia alimentaria, la resistencia a enfermedades y la tolerancia al estrés en especies acuícolas. Este estudio evaluó bacterias aisladas del intestino y las branquias de la gamitana (Colossoma macropomum) con base en criterios clave de selección de probióticos. Se obtuvo un total de 69 aislados bacterianos utilizando caldo Man, Rogosa y Sharpe (MRS) y caldo de soya tripticasa (TSB). Cinco aislados (7,2%) cumplieron con todos los criterios de selección y fueron identificados como Lactobacillus brevis y Lactococcus garvieae. L. brevis mostró una tolerancia moderada al ácido, con tasas de supervivencia entre 31 % y 36,4 % a pH 4. Todas las cepas seleccionadas toleraron las sales biliares; sin embargo, L. brevis mantuvo una alta viabilidad (≥78% al 0,8%), mientras que L. garvieae exhibió reducciones marcadas a concentraciones más altas. La actividad antagónica fue significativamente mayor en L. brevis, produciendo halos de inhibición de 2,3 a 3,9 mm, en comparación con 1,2 a 1,9 mm para L. garvieae. Se observó actividad proteolítica en tres cepas de L. brevis, y seis aislados demostraron capacidad de formación de biopelículas. Todas las cepas seleccionadas fueron susceptibles a los antibióticos probados. Entre ellos, L. brevis IPIFAB2 exhibió el perfil probiótico más fuerte. En general, las cepas de L. brevis muestran un potencial considerable como probióticos autóctonos para la acuicultura de C. macropomum, contribuyendo a mejorar la salud de los peces, la prevención de enfermedades y la producción sostenible.Instituto de Investigaciones de la Amazonia Peruana2025-06-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticlesArtículosapplication/pdfhttps://revistas.iiap.gob.pe/index.php/foliaamazonica/article/view/80310.24841//fa.v34i1.803Folia Amazonica; Vol. 34 No. 1 (2025); e34803Folia Amazónica; Vol. 34 Núm. 1 (2025); e34803Folia Amazónica; v. 34 n. 1 (2025); e348032410-11841018-567410.24841/fa.v34i1reponame:Folia Amazónicainstname:Instituto de investigaciones de la Amazonía Peruanainstacron:IIAPenghttps://revistas.iiap.gob.pe/index.php/foliaamazonica/article/view/803/677Derechos de autor 2025 Odalis Epifanía TOLEDO VALDIVIEZO, Adrian E. ZATAN, Arnaldo Edward CASTAÑEDA, Jorge Luis AGUILAR, Iñigo MANEIRO, Benoit DIRINGER, Manuel Alberto FERIAhttps://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/8032026-01-14T20:30:17Z
score 12.824051
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).